Establishment Labs Holdings (ESTA) Profit After Tax Growth (1y) (2018 - 2026)
Powered by 
Analysis
Establishment Labs Holdings (ESTA) Profit After Tax Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | 18.51% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 41.26% |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | 13.84% |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | -27.98% |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | 12.92% |
| 10 | Establishment Labs Holdings | 2.25 Bn | 2.18 Bn | 47.71 Mn | 29.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.20% |
| Mar 31, 2026 | 35.38% |
| Dec 31, 2025 | 92.43% |
| Sep 30, 2025 | 33.19% |
| Jun 30, 2025 | 3.42% |
| Mar 31, 2025 | -27.82% |
| Dec 31, 2024 | -68.10% |
| Sep 30, 2024 | 43.01% |
| Jun 30, 2024 | -2.60% |
| Mar 31, 2024 | -35.67% |
| Dec 31, 2023 | -51.47% |
| Sep 30, 2023 | -57.31% |
| Jun 30, 2023 | 54.87% |
| Mar 31, 2023 | -101.28% |
| Dec 31, 2022 | 4.43% |
| Sep 30, 2022 | -26.77% |
| Jun 30, 2022 | -597.22% |
| Mar 31, 2022 | 14.61% |
| Dec 31, 2021 | -151.12% |
| Sep 30, 2021 | -245.77% |